share_log

そーせいグループ:統合失調症の全症状を治療対象としたファーストインクラス治療薬の共同開発に関する新規提携のお知らせ

Sosei Group: Announcement of a new partnership regarding joint development of first-in-class therapeutics targeting all symptoms of schizophrenia

JPX ·  Mar 11 02:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more